We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+9.24%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$109B
AUM Growth
+$6.58B
Cap. Flow
-$2.53B
Cap. Flow %
-2.32%
Top 10 Hldgs %
11.22%
Holding
2,919
New
123
Increased
1,147
Reduced
1,380
Closed
157

Sector Composition

Rank Sector Weight
1 Technology 17.78%
2 Industrials 13.97%
3 Financials 11.99%
4 Consumer Discretionary 10.9%
5 Healthcare 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STON
2626
DELISTED
StoneMor Inc.
STON
$38K ﹤0.01%
16,487
-507
-3% -$1.27K
NPKI
2627
NPK International
NPKI
$1.14B
$37K ﹤0.01%
12,616
-367
-3% -$1.18K
ASXC
2628
DELISTED
Asensus Surgical, Inc.
ASXC
$36K ﹤0.01%
32,050
-988
-3% -$1.53K
POL
2629
DELISTED
Polished.com Inc.
POL
$35K ﹤0.01%
294
-9
-3% -$1.21K
NMTR
2630
DELISTED
9 Meters Biopharma
NMTR
$35K ﹤0.01%
1,804
-49
-3% -$1.1K
OWLT icon
2631
Owlet
OWLT
$160M
$32K ﹤0.01%
856
-231
-21% -$12.3K
CTIC
2632
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$32K ﹤0.01%
13,082
+205
+2% +$502
NCMI icon
2633
National CineMedia
NCMI
$378M
$31K ﹤0.01%
1,090
-41
-4% -$1.3K
CEI
2634
DELISTED
Camber Energy, Inc
CEI
$31K ﹤0.01%
720
+417
+138% +$26.8K
MTNB icon
2635
Matinas BioPharma
MTNB
$1.81M
$30K ﹤0.01%
591
-15
-2% -$802
PAVM icon
2636
PAVmed
PAVM
$33.9M
$30K ﹤0.01%
27
+2
+8% +$4.35K
XWEL icon
2637
XWELL
XWEL
$8.61M
$30K ﹤0.01%
753
-23
-3% -$729
TALK icon
2638
Talkspace
TALK
$874M
$29K ﹤0.01%
14,624
-4,103
-22% -$11.7K
TCRT icon
2639
Alaunos Therapeutics
TCRT
$4.86M
$29K ﹤0.01%
180
-5
-3% -$1.1K
ATOS icon
2640
Atossa Therapeutics
ATOS
$23.5M
$28K ﹤0.01%
1,154
-36
-3% -$1.32K
FBIO icon
2641
Fortress Biotech
FBIO
$88.7M
$28K ﹤0.01%
754
-44
-6% -$1.96K
AVTX icon
2642
Avalo Therapeutics
AVTX
$983M
$27K ﹤0.01%
6
+1
+20% +$6K
CNVS icon
2643
Cineverse
CNVS
$65.6M
$27K ﹤0.01%
1,170
+113
+11% +$4.3K
DRRX
2644
DELISTED
DURECT Corp
DRRX
$27K ﹤0.01%
2,747
-85
-3% -$939
IMDX
2645
Insight Molecular Diagnostics
IMDX
$156M
$27K ﹤0.01%
631
-15
-2% -$863
INFI
2646
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$27K ﹤0.01%
12,173
-337
-3% -$846
SNCR
2647
DELISTED
Synchronoss Technologies
SNCR
$26K ﹤0.01%
1,199
-35
-3% -$797
TNXP icon
2648
Tonix Pharmaceuticals
TNXP
$192M
0
EPZM
2649
DELISTED
Epizyme, Inc
EPZM
$26K ﹤0.01%
10,580
-156
-1% -$613
SPPI
2650
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$25K ﹤0.01%
20,035
-638
-3% -$1.14K

Similar funds

Victory Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Victory Capital Management held 2,919 positions worth $109B, up 6.4% from $102B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Victory Capital Management's Q4 2021 filing shows 123 new, 1,147 increased, 1,380 reduced and 157 closed positions. Its largest new stake was Victory Portfolios II VictoryShares Core Plus Bond ETF: 7,796,100 shares worth $194M. The largest sale was HILL-ROM HOLDINGS, INC., an estimated $373M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

  • Victory Capital Management's largest Q4 2021 buy was Victory Portfolios II VictoryShares Core Plus Bond ETF: 7,796,100 shares worth $194M.
  • Victory Capital Management added most to Global Payments in Q4 2021, an estimated $382M increase.
  • Victory Capital Management's biggest Q4 2021 reduction was Highwoods Properties, cutting an estimated $199M.
  • Victory Capital Management fully exited HILL-ROM HOLDINGS, INC. in Q4 2021, selling an estimated $373M.
  • Victory Capital Management's ten largest holdings make up 11% of its $109B portfolio in Q4 2021.
  • Victory Capital Management opened 123 new positions and closed 157 in Q4 2021.
  • Victory Capital Management's portfolio value rose 6.4% quarter-over-quarter to $109B.

Based on Victory Capital Management's 13F filing for Q4 2021, filed 7 Feb 2022.